+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Sinusitis Pipeline Insight Analysis Report - Product Thumbnail Image

Sinusitis Pipeline Insight Analysis Report

  • Drug Pipelines
  • August 2024
  • 150 Pages
  • Global
From
Chlorpheniramine Maleate Market Report and Forecast 2024-2032 - Product Thumbnail Image

Chlorpheniramine Maleate Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 140 Pages
  • Global
From
Sarcopenia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Sarcopenia Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
  • Global
From
From
Cystic Fibrosis Therapeutics Market - Product Thumbnail Image

Cystic Fibrosis Therapeutics Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
Epinephrine Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Epinephrine Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2024

  • Clinical Trials
  • January 2024
  • 454 Pages
  • Global
From
COPD: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

COPD: Seven-Market Drug Forecast and Market Analysis

  • Report
  • September 2024
  • 128 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more